Kendall Park, NJ, United States of America

Karuna Sundarapandiyan

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2008-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Karuna Sundarapandiyan

Introduction

Karuna Sundarapandiyan is a prominent inventor based in Kendall Park, NJ (US). She has made significant contributions to the field of immunology, particularly through her work on agonistic antibodies. With a total of five patents to her name, her innovations have the potential to impact therapeutic and diagnostic methods in medicine.

Latest Patents

Among her latest patents is the development of agonistic antibodies that bind to human CD40 and their various uses. These isolated monoclonal agonistic antibodies are designed to enhance immune responses, providing new avenues for treatment. The patents also disclose related antibody-based compositions and molecules, showcasing her innovative approach to immunotherapy.

Career Highlights

Karuna has worked with notable companies in the biotechnology sector, including Celldex Therapeutics Limited and Medarex Inc. Her experience in these organizations has allowed her to collaborate on groundbreaking research and development projects that advance the understanding of immune responses.

Collaborations

Throughout her career, Karuna has collaborated with esteemed colleagues such as Tibor P Keler and Joel Goldstein. These partnerships have contributed to her success and the advancement of her research in the field of immunology.

Conclusion

Karuna Sundarapandiyan's work exemplifies the spirit of innovation in the field of immunology. Her patents and collaborations highlight her commitment to advancing medical science and improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…